Perspectives on Outsourcing

Apr 01, 2011
BioPharm International
By BioPharm International Editors
Mergers and acquisitions expected to increase, as big companies bolster piplines by acquiring smaller biotech companies.
Mar 01, 2011
BioPharm International
Indian manufacturers are not now a threat to Western CMOs, but may be long term.
Jan 01, 2011
BioPharm International
CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Dec 01, 2010
BioPharm International
Covance's deal with Sanofi-Aventis demonstrates the power of scale and scope.
Oct 01, 2010
BioPharm International
Venture capital is still scarce for early biotechs and their providers.
Sep 01, 2010
BioPharm International
By BioPharm International Editors
How current economic conditions affect your build-or-buy decision.
Aug 01, 2010
BioPharm International
This month, we catch up on major developments around the world and their implications for the contract services industry.
Jul 01, 2010
BioPharm International
How much to spend on early development, whether to use your CMO's proprietary cell line, and other outsourcing advice.
Jun 01, 2010
BioPharm International
Being open to unforseen events may avert risk or create opportunities.
May 01, 2010
BioPharm International
By BioPharm International Editors
Formulation strategy is an important consideration when selecting and managing outsourced biopharmaceutical development programs.
native1_300x100
lorem ipsum